drugset / Trial / NCT00637715

Once Daily Given Alfuzosin in the Treatment of BPH

NCT00637715

Phase 4 Completed 60 enrolled Sanofi
Non-randomizedSingle-groupOpen-labelTreatment

Summary

Collection of the data on the safety and efficacy of the once daily administration of the alfuzosin preparation /Alfetim Uno® l0 mg/ at patients with lower urinary tract symptoms/complaints rendering possible the presence of benign prostatic hyperplasia, in the course of everyday practice

Timeline

Start
2003-10
Primary completion
Completion
2004-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Alfuzosin Small molecule 10 mg